ARTICLE | Company News
Elan, PharmatrophiX deal
July 13, 2009 7:00 AM UTC
PharmatrophiX granted Elan an exclusive, worldwide license to develop and commercialize its two preclinical compounds targeting p75 neurotrophin receptor (p75 NTR) for neurologic indications. The lea...